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Anisotropy of solid breast lesions in 2D Shear Wave 
Elastography is an indicator of malignancy 
Abstract 
 Rationale and Objectives: To investigate if anisotropy at 2D Shear 
Wave Elastography (SWE) suggests malignancy and whether it correlates 
with prognostic and predictive factors in breast cancer. 
Materials and Methods: Study-group A of 244 solid breast lesions was 
imaged with SWE between April 2013 and May 2014. Each lesion was 
imaged in radial and anti-radial planes and the maximum elasticity Emax, 
mean elasticity Emean and standard deviation SD were recorded and 
correlated with benign/malignant status and if malignant, to conventional 
predictive and prognostic factors. The results were compared to a study-group 
B of 968 solid breast lesions, which were imaged in sagittal and axial plane 
between 2010 and 2013. 
Results: Neither benign nor malignant lesion anisotropy is plane dependent. 
However, malignant lesions are more anisotropic than benign lesions 
(p≤0.001). Anisotropy correlates with increasing elasticity parameters, 
BIRADS categories, core biopsy result and tumour grade. Large cancers are 
significantly more anisotropic than small cancers (p≤0.001). The optimal 
anisotropy cut-off threshold for benign/malignant differentiation of 150 kPa
2
 
achieves the best sensitivity (74%) with a reasonable specificity (63%). 
*Manuscript (excl. author details)
Click here to view linked References
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
2 
Conclusions: Anisotropy may be useful during benign/malignant 
differentiation of solid breast masses using SWE. Anisotropy also correlates 
with some prognostic factors in breast cancer. 
Keywords: Elastography, breast, breast cancer, ultrasound, Shear Wave 
Elastography 
 
Introduction 
Supersonic Shear Wave Elastography (SWE) is an ultrasound 
imaging modality which visualizes the elasticity of tissue. It 
was introduced by Bercoff et al. in 2004 [1] and has been in 
clinical use since 2009 [2]. During examinations the 
propagation speed of the shear wave is measured and the 
elasticity, represented as Young’s Modulus E, is calculated as  
 E=3ϱc
2
 (1) 
where c is the propagation speed of the shear wave and ϱ is the 
density of the tissue. Thus SWE is a quantitative measurement 
method. The elasticity is visualised as a colour map 
overlaying the grey-scale B-mode ultrasound image of the 
lesion. As the shear wave is induced by applying an acoustic 
radiation force, there is no need to move the transducer. A 
good inter-observer reproducibility can be achieved [2]. 
Furthermore, Berg et al. have shown that analysing the 
Abbreviations 
AD – anistropic difference 
(difference of the measurements in 
each plane) 
AF – anisotropy factor (square of 
AD) 
AUC – area under the curve 
(statistic measurement to evaluate 
the diagnostic performance of a 
method) 
E – Young’s Modulus 
(measurement unit of tissue 
elasticity) 
Emax – maximum elasticity 
Emean – mean elasticity 
ROC – receiver operator 
characteristics (statistical tool to 
evaluate the diagnostic 
performance of a method) 
ROI – region of interest 
SD – standard deviation 
SWE – Shear Wave Elastography 
(used elastography technique in the 
paper) 
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3 
quantitative elasticity of a lesion with SWE is useful for the differentiation of benign and malignant 
lesions [2] as malignant tissue is generally stiffer than benign tissue [3]. Berg et al. recommended 
the use of a cut-off threshold for the maximum elasticity, Emax of 80 kPa for the optimal 
benign/malignant differentiation [2]. Evans et al. recommend a cut-off threshold for the mean 
elasticity, Emean of 50 kPa [4]. 
Evans et al. obtain four SWE images per lesion; each two in two orthogonal planes [5]. Observation 
of anisotropy during routine SWE evaluation of breast lesions prompted this study. Although 
Ciurea et al. observed anisotropy in solid breast lesions in 2011 [6], to our knowledge there have 
been no publications on the evaluation of the anisotropy of solid breast lesions on SWE to date. 
Anisotropy is found in normal breast tissue and breast lesions. Ductal carcinoma in situ (DCIS) is 
known to grow faster in the radial than anti-radial plane [7]. Furthermore collagen alignment has 
been shown to be prognostic in invasive breast cancer [8]. This suggests that detection of anisotropy 
in SWE could potentially help characterise lesions with ultrasound.  
The aim of this study was to observe the frequency and directional characteristics of anisotropy at 
SWE in benign and malignant lesions and correlate anisotropy with prognostic and predictive 
factors in breast cancer. 
Materials and methods 
Study-groups 
Study-group A comprised 244 solid lesions visible on ultrasound (78 benign, 166 malignant) in 243 
patients (age range 17-92, mean 58) scanned in our clinic between April 2013 and May 2014. For 
each lesion four images were obtained; first two in the radial plane and then two in the anti-radial 
plane. As preliminary data from a sub-group of the study-group A (174 of the 244 lesions in 
study-group A) suggested that anisotropy in solid breast lesions is not plane dependent [9], another 
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4 
study-group B of 968 solid breast lesions (306 benign, 662 malignant) in 949 patients (age 17-95, 
mean 57) was also evaluated. For this group, images had been obtained in two orthogonal planes 
unrelated to the radial plane. The lesions of the study-group B were evaluated between 2010 and 
April 2013. Some of the 968 lesions in study-group B were evaluated in previous studies 
investigating the diagnostic performance of SWE (53 lesions [5], 165 lesions [4]), its correlation 
with prognostic factors (101 lesions [10]), lymph node involvement (396 lesions [11]) and tissue 
subtypes (302 lesions [12]) and whether SWE stiffness suggests response to neoadjuvant 
chemotherapy (40 lesions [13]). However, anisotropy was not measured on any of the SWE 
examinations in any of the previous studies. 
Only patients who underwent core biopsy or surgical excision were included. Women with 
BIRADS 3 lesions younger than 25 years old did not undergo biopsy or short term follow up in our 
institution. Further exclusion criteria did not apply. Ethical approval by the National Research 
Ethics Service guidance was not necessary for this retrospective study [14]. Written informed 
consent for research purposes was available according to standard procedure in our clinic. 
Ultrasound device 
All examinations were performed using the ultrasound device Aixplorer (SuperSonic Imagine, Aix 
en Provence, France). The probe that was used to acquire the greyscale and SWE images had a 
frequency range of 4 to 15 MHz, which gives at -6 dB an axial resolution of 0.3 to 0.5 mm and a 
lateral resolution of 0.3 to 0.6 mm.  
Image evaluation 
All images were obtained by observers with 5-20 years’ experience in breast ultrasound and at least 
3 months experience in the performance of SWE. All four images in the two orthogonal planes were 
evaluated using a region of interest (ROI) size of 2 mm positioned at the stiffest point of Emean in 
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the lesion or the surrounding tissue Artefacts and areas without measured elasticity (black on the 
colour-map) were excluded. Each image plane was centred at the approximated centre of the lesion. 
The elasticity parameters Emax, Emean and standard deviation (SD) were measured. To evaluate the 
anisotropic behaviour of the lesions the two measurements of Emean for each plane were averaged. 
To estimate the plane dependence the anisotropic difference (AD) of the estimations per plane in 
study-group A was calculated as  
 AD = antiradial − radial (2) 
To evaluate the general plane independent anisotropy of the lesion the anisotropy factor (AF) was 
calculated as the squared anisotropic difference:  
 AF=(antiradial−radial)
2
 (3) 
Study-group B was imaged randomly in sagittal and axial plane. Therefore a plane dependency 
could not be evaluated but the anisotropy factor:  
 AF=(sagittal−axial)
2
 (4) 
The results of these calculations were compared to the histological features. Furthermore the 
diagnostic performance of the anisotropic difference and the anisotropy factor were calculated. The 
gold standard was histology from core biopsy or surgery. 
BIRADS classification of the grey scale images was performed by an experienced breast radiologist 
blinded to the SWE and histological findings. 
Core biopsy results were classified as recommended by the NHSBSP in [15], which is: Category B1 
- unsatisfactory or normal tissue; category B2 - benign tissue; category B3 - tissue of uncertain 
malignant potential; category B4 - suspicious tissue; category B5a - malignant tissue in situ; 
category B5b - invasive tissue; category B5c - not assessable. 
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Statistics 
The Receiver Operator Characteristic (ROC) analysis and statistical analysis using the T-test was 
performed using IBM SPSS (IBM, Armonk, New York, USA). 
The performance of the different thresholds was compared with web-based software using 
Chi-square test. The null hypothesis was rejected at a level of 5% (p≤0.05). 
Results 
Evaluation of the study-groups 
The 244 lesions of group A comprised 78 benign lesions and 166 malignant lesions. Three hundred 
and six of the 968 lesions in group B were benign and 662 lesions, malignant. The distribution of 
histology of each group is shown in Table 1; the distribution off screen detected and symptomatic 
lesions is shown in Table 2. The ultrasound imaging and histological features are also shown in 
Table 2.  
Plane dependency 
To investigate any correlation of the anisotropy of solid breast lesions with the anatomic structure 
of the breast, the AD of study-group A was evaluated. Fig. 1 shows the distribution of lesions stiffer 
in the radial plane (AD<0) and lesions stiffer in the anti-radial plane (AD>0).  
No plane dependency of anisotropy could be found in any of the lesions whether benign or 
malignant. This result was confirmed by ROC analysis (Fig. 2) with an area under the curve (AUC) 
of 0.49 for benign/malignant differentiation. 
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7 
Anisotropy threshold 
The anisotropic factor (AF) was calculated. The AF is plane independent and indicates the degree 
of anisotropy. In Fig. 2 the ROC analysis for the correlation of AF with 
benign/malignant-differentiation is shown. For comparison the ROC of the elasticity parameters 
Emax and Emean are also shown.  
With an AUC of 0.67, the AF suggests malignancy. However, the diagnostic performance of the AF 
is not as good as Emax or Emean (AUC for both 0.81). Calculation of the Youden’s index gives an 
optimal cut-off threshold of AF=200 kPa
2
. In Table 3 the diagnostic performance for different 
thresholds of AF around the calculated Youden’s Index is shown.  
A threshold of 150 kPa
2
 yielded the best sensitivity with a reasonably good specificity. This result 
was confirmed analysing group B. The overall diagnostic performance of thresholds of 
AF=200 kPa
2
 and AF=250 kPa
2
 was identical in group A. However, in group B a cut-off value of 
AF=250 kPa
2
 yielded the best overall performance. ROC analysis was in agreement with these 
thresholds. 
Correlation with source of referral 
To evaluate the correlation of anisotropy and the source of the referral, groups A and B were 
subdivided into screen detected or symptomatic lesions, and further subdivided into benign and 
malignant lesions. The AF of each subgroup was averaged and evaluated. 
Fig. 3 shows the averaged AF for all sub-groups in groups A and B.  
In group A all sub-groups of symptomatic lesions are significantly more anisotropic than screen 
detected lesions (p≤0.005 for total and malignant, p≤0.05 for benign lesions). In study-group B the 
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8 
results are similar for the sub-groups of all (total) and malignant lesions. However, symptomatic 
benign lesions are not significantly more anisotropic than screen detected lesions (p=0.4).  
Correlation with Ultrasound Imaging and elasticity characteristics 
The dependence of anisotropy on the size of the lesion (ultrasound diameter) and the elasticity 
parameters (Emax, Emean and SD) was evaluated. Therefore the lesions of group A and B 
dichotomised according to a threshold for each parameter, identified from the literature [2, 5, 16] as 
follows: that is an ultrasound diameter of 15 mm, Emax of 80 kPa, Emean of 50 kPa and a SD of 
7 kPa. Furthermore the sub-groups were divided into all (total), benign and malignant lesions. The 
results are shown in Fig. 4.  
Overall, large lesions (≥15 mm) are significantly more anisotropic than small lesions (<15 mm) 
(p≤0.001). In particular, large malignant lesions are significantly more anisotropic than small 
cancers (p≤0.001). However, this correlation is not significant for benign lesions and may even be 
independent of lesion size when the results in group B are considered. 
A very strong correlation between anisotropy and the elasticity parameters Emax and Emean was 
found (p≤0.001 for all sub-groups in groups A and B). However, in the sub-groups below and above 
the threshold the AF of benign and malignant lesions are similar. In group A, benign lesions with 
high elasticity were even more anisotropic than malignant lesions of high elasticity. However, this 
was not observed in group B. 
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Anisotropy also correlates with the elasticity parameter SD (p≤0.001 for the sub-groups of all and 
benign lesions). The correlation with SD in the sub-group of malignant lesions was non significant 
in group A, but significant in group B (p≤0.001), which is probably due to a greater number of cases 
in group B. For the sub-groups with SD<7 kPa, - malignant lesions are significantly more 
anisotropic than benign lesions (p≤0.05). However, all lesions of group A with SD≥7 kPa are in the 
same range and a difference of AF in benign and malignant lesions was seen only in group B 
(p≤0.001).  
Correlation with ultrasound BIRADS 
Groups A and B were divided into subgroups by ultrasound BIRADS categorisation. Furthermore 
the subgroups were divided into benign and malignant lesions. The averaged AF of each sub-group 
was correlated with ultrasound BIRADS categories (Fig. 5).  
A correlation of the averaged AF and ultrasound BIRADS categories was observed. Overall lesions 
categorised as BIRADS 3 are less anisotropic than BIRADS 4a lesions (significant in group A with 
p≤0.05; not significant in group B, p≤0.1) and BIRADS 4a lesions are significantly less anisotropic 
than BIRADS 4b lesions (p≤0.05 for both groups). The difference in the averaged AF of benign and 
malignant lesions is non significant in BIRADS 3 as the number of malignant cases was low (one 
case) and significant in BIRADS 4a lesions (p≤0.001).  
Correlation with core result 
Groups A and B were subdivided according to the core biopsy result. The averaged AF was then 
correlated with results of core biopsy (Fig. 6).  
The AF correlates with the core result; in general a more anisotropic lesion is more likely to be 
malignant. Lesions with a core result of B1, B2 or B3 are significant less anisotropic than lesions 
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10 
with a core result of B5a (p≤0.001 in both groups). Furthermore B5b lesions are more anisotropic 
than B5a lesions (p>0.1 in group A, p≤0.001 in group B). 
Correlation with tumour grade 
Malignant lesions in groups A and B were subdivided according to tumour grade and correlated 
with AF as shown in Fig. 7.  
While the AF of lesions with a tumour grade of 2 and 3 are in the same range, lesions with a tumour 
grade of 1 are significantly less anisotropic (p≤0.001 in both groups). 
Correlation with other histological features 
The averaged AF was correlated with the HER2, PR and ER receptor status. There was no 
correlation found. Lesions with HER+/- had an AF of 21 vs. 23 kPa
2
/100 in group A and 24 vs. 23 
kPa
2
/100 in group B. Lesions with ER+/- had an AF of 22 vs. 27 kPa
2
/100 in group A and 24 vs. 22 
kPa
2
/100 in group B. Lesions with PR+/- had an AF of 24 vs. 21 kPa
2
/100 in group A and 24 vs. 22 
kPa
2
/100 in group B. 
Furthermore no correlation could be found with lymph node involvement (23 vs. 22 kPa
2
/100 in 
group A; 25 vs. 23 kPa
2
/100 in group B for lymph node positive/negative) nor vascular invasion (18 
vs. 24 kPa
2
/100 in group A; 26 vs. 23 kPa
2
/100 in group B for vascular invasion positive/negative). 
 
Correlation with subtypes 
The benign and malignant lesions of groups A and B were divided into their subtypes. The averaged 
AF of each tissue subtype was calculated and is shown in Table 4. Mucinous and tubular 
carcinomas are less anisotropic than other malignant lesions while ductal carcinomas of no specific 
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11 
type and lobular carcinomas are more anisotropic in both groups. A difference between group A 
and group B is visible which may be caused by the small numbers in each subgroup.  
Discussion 
We have shown that solid breast lesions are anisotropic at SWE assessment. Neither benign nor 
malignant lesions show consistent plane-dependent anisotropy; that is, elasticity may be greater in 
either radial or anti-radial plane regardless of the nature of the lesion. However, the degree of 
anisotropy represented by AF suggests malignancy. The optimal cut-off threshold for 
benign/malignant differentiation in group A, in whom elasticity was assessed in radial and 
anti-radial planes, was calculated to be 200 kPa
2
. A threshold of AF=150 kPa
2
 resulted in the best 
sensitivity with a reasonable specificity; if specificity is more important, a threshold of 
AF=250 kPa
2
 is preferable. These results were confirmed by analysing group B, where images 
were acquired in sagittal and axial planes. 
Breast tissue is anisotropic in structure as the fibroglandular tissue is oriented along the ducts 
leading radially to the nipple. For ductal elongation local collagen fibre alignment is necessitated 
which leads to local mechanical anisotropy in the mammary gland [17]. Provenzano et al. have 
shown that the orientation of collagen fibres changes during tumour growth: first regions of dense 
collagen develop in the tissue, then the collagen fibres are aligned parallel to the tumour boundary 
while during further tumour growth, collagen fibres become reorganized orthogonal to the tumour 
boundary to enable invasion [18].  
The higher anisotropy in the elasticity of malignant breast lesions may therefore correlate with the 
degree of invasiveness. Furthermore, the stiffest plane could suggest the growing direction of the 
tumour. This would also explain the higher anisotropy in invasive lesions. It is possible that the 
observed anisotropy in in situ lesions may correlate with the invasive potential of the lesion. 
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The anisotropy of solid breast lesions can also be evaluated with diffusion tensor magnetic 
resonance imaging (DTI), which quantifies the directionality, if any, of diffusion of water 
molecules in response to motion-probing local magnetic field gradients. In normal breast tissue, 
water diffusion is anisotropic with a predominant vector towards the nipple (ie. along the radial 
plane). Previous studies have shown that evaluating the anisotropy may be helpful for 
benign/malignant differentiation [19 - 22]. They found malignant lesions more anisotropic than 
benign lesions [19, 21] which is in agreement with our results. 
Anisotropy was also evaluated by Sinkus et al. using magnetic resonance elastography (MRE) [23]. 
They found that anisotropy of solid breast lesions correlates with the degree of stiffness. However, 
only two solid breast lesions (one fibroadenoma, one invasive ductal carcinoma) were included into 
their study. Our results confirm and expand on their findings. 
Our study does have some limitations. Groups A and B were subdivided and the AF was averaged 
for each subgroup. However, evaluating the mean can be misleading if outliers are present 
particularly in small subgroups. 
SWE measurements were only made in two orthogonal planes. Therefore it is uncertain if the 
stiffest plane of the tumour was measured, which may distort the results. 
Furthermore the elasticity is calculated by the ultrasound system using equation 1, which is a 
simplified equation and might hence influence the measurements. However, our aim was to 
investigate anisotropy observed during clinical practice.  
A further limitation is that this study was a single centre study, retrospective study, though care was 
taken to minimise bias by blinding the observer to the final pathology of the lesions, and the 
observer carrying out the greyscale BIRADS classification was not the one measuring the 
anisotropy. 
To our best knowledge this study is the first to investigate the significance of anisotropy of solid 
breast lesions on SWE. The elasticity parameters should be investigated in further planes to enable 
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the inclusion of the evaluation of the stiffest plane. Furthermore an investigation of the position of 
the lesion within the entire breast may be of interest. 
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Figure Captions 
Figure 1: Neither benign nor malignant lesions’ stiffness is plane dependent. The distribution of 
lesions stiffer in the anti-radial plane (orthogonal to ducts) equals the distribution of lesions, which 
are stiffer in the radial plane (along ducts). 
Figure 2: ROC curve of the plane dependent anisotropic difference (AD) and the plane independent 
anisotropy factor (AF) compared to the performance of Emax and Emean in group A. AD does not 
correlate with malignancy but AF. However, the diagnostic performance of AF is inferior to that of 
Emax or Emean. 
Figure 3: Symptomatic lesions’ stiffness is more anisotropic than screen detected lesions. 
Figure 4: Larger lesions are more anisotropic on SWE than smaller lesions. Small benign lesions 
are less anisotropic than small cancers; large benign lesions are less anisotropic than large cancers. 
Furthermore, anisotropy on SWE correlates with stiffness (Emax, Emean, SD). There is no further 
correlation of AF with malignancy in soft or hard lesions. 
Figure 5: BIRADS 3 and 4a lesions are less anisotropic on SWE than BIRADS 4b, 4c or 5 lesions. 
Malignant BIRADS 3 or 4a lesions are more anisotropic than benign BIRADS 3 or 4a lesions.  
Figure 6: Anisotropy on SWE correlates with the result of core biopsy. Invasive cancers (B5b) are 
more anisotropic than in-situ cancers (B5a). 
Figure 7: Tumours with grade 1 are less anisotropic on SWE than tumours with grade 2 or 3. 
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     study-group A study-group B 
Subtype   number % number % 
Malignant ductal carcinoma in situ 4 2 18 3 
 
ductal carcinoma of no specific type 110 68 482 76 
 
lobular carcinoma 34 21 78 12 
 
mucinous carcinoma 7 4 9 1 
 
tubular carcinoma 6 4 23 4 
 
papillary carcinoma 1 1 17 3 
 
Other 5 31 26 4 
Benign Fibroadenoma 43 69 148 55 
 
Fibrocystic changes 7 11 56 21 
 
Liponecrosis 3 5 15 6 
 
Papilloma 1 2 14 5 
 Other 8 13 38 14 
Table 1: Subtypes of solid breast lesions in the study-group A and study-group B 
 
Table
    study-group A study-group B 
Feature   number % number % 
Source screening 75 31 339 35 
 
symptomatic 170 69 629 65 
Imaging US size <15mm 115 47 454 47 
 
US size ≥15mm 130 53 514 53 
 
US BIRADS 3 34 14 53 11 
 
US BIRADS 4a 25 10 68 15 
 
US BIRADS 4b 28 11 88 19 
 
US BIRADS 4c 70 29 109 23 
 
BIRADS 5 88 36 152 32 
 
Emax<80kPa 97 40 336 35 
 
Emax ≥80kPa 148 60 615 65 
 
Emean<50kPa 73 30 250 26 
 
Emean≥50kPa 172 70 717 74 
 
SD<7kPa 104 42 393 41 
 
SD≥7kPa 141 58 572 59 
Histology Core result B1 0 0 7 1 
 
Core result B2 70 29 261 27 
 
Core result B3 8 3 39 4 
 
Core result B5a 9 4 33 3 
 
Core result B5b 158 64 626 65 
 
Core result B5c 0 0 2 0 
Characteristics HER2+ 15 10 85 13 
of invasive 
cancers ER+ 136 83 522 81 
 
PR+ 111 68 437 68 
 
Grade 1 15 9 71 11 
 
Grade 2 85 52 274 43 
 
Grade 3 65 39 289 46 
 
Lymph node 
positive 49 38 174 31 
 Vascular invasion 40 31 156 28 
Size, nodal status and vascular invasion were not available in those women treated initially with systematic 
therapy. HER status is missing in women with equivocal ELISA results who were not candidates for 
chemotherapy. 
Table 2: Ultrasound assessment and histological features of the study-group A and the study-
group B 
 
Table
   study-group A study-group B 
Threshold Se Sp DA Se Sp DA 
150 74 63 71 72 59 68 
200 70 68 69 69 62 67 
250 68 71 69 68 68 68 
Table 3: Diagnostic performance of anisotropy factor (AF) 
 
Table
Subtype   study-group A study-group B 
    AF [kPa2/100] AF [kPa2/100] 
Benign Fibroadenoma 5 4 
 
Fibrocystic changes 6 13 
 
Liponecrosis 42 4 
 
Papilloma 6 5 
 
Other 13 8 
Malignant ductal carcinoma in situ 26 7 
 
ductal carcinoma of no specific type 23 24 
 
lobular carcinoma 32 24 
 
mucinous carcinoma 5 11 
 
tubular carcinoma 7 15 
 
papillary carcinoma 2 32 
 Other 17 22 
Table 4: Correlation of AF with tissue subtype of the lesions of study-group A and B 
 
Table
